Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Pagaya Technologies debut $500 million senior notes offering
We advised Pagaya on its debut high-yield notes offering
MARA Holdings $950 million convertible notes offering
The 0% convertible senior notes are due 2032
Baker Hughes $14.9 billion Chart Industries acquisition financing
We are advising the lead arrangers and agent on the facility
Travelers $1.25 billion senior notes offering
The investment-grade notes are due 2035 and 2055
Century Aluminum $400 million senior secured notes offering
The high-yield notes are due 2032
Ether Machine de-SPAC transaction and $1.5 billion committed PIPE financing
The PIPE transaction will be the largest all-common-stock financing committed at announcement since 2021
Morgan Stanley Private Bank inaugural $6 billion senior notes offering
We advised Morgan Stanley Private Bank on its inaugural 3(a)(2) notes offering
MP Materials $747.4 million follow-on offering
The shares are listed on the New York Stock Exchange
Aura Minerals $196.4 million U.S. IPO
We advised Aura Minerals on its U.S. IPO and Nasdaq listing
Carrefour €171 million sale of shares in Carmila
We advised the selling shareholder on the transaction